MP CARDIOFLOW-B (02160) announced that its board of directors has recommended a share consolidation. The proposal is to consolidate the company's share capital on the basis of every five issued and unissued existing shares, each with a par value of US$0.000005, into one consolidated share with a par value of US$0.000025.
As of the date of this announcement, the existing shares are traded on The Stock Exchange of Hong Kong in board lots of 1,000 existing shares per trading unit.
Following the effectiveness of the share consolidation, the board lot size for trading on the Exchange will remain unchanged at 1,000 consolidated shares per trading unit.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.